Risk-reducing salpingo-oophorectomy is currently recommended for patients with breast cancer between 35 and 40 years of age for those with a BRCA1 pathogenic variant and between 40 and 45 years for those with a BRCA2 pathogenic variant [9]. The gene discussed is BRCA1; the disease is breast carcinoma.